Dr Richard Quek is the Deputy Head of Division, Medical Oncology, National Cancer Centre Singapore (NCCS). He is also the Programme Director of Medical Oncology Senior Residency Programme charged with the development of the next generation of medical oncologists in his institution. His main clinical and research focus is in the area of sarcomas and gastrointestinal stromal tumours (GIST).
As a key member of his institution's sarcoma multi-disciplinary care team, Dr Quek is heavily involved in the care and management of patients with sarcomas and GIST. Dr Quek's chief research interest is primarily focused on translational therapeutics, developing new molecularly targeted therapeutics in sarcoma and GIST in an academic environment.
Having returned from a 2-year sarcoma fellowship at Dana-Farber / Harvard Cancer Centre, Boston, USA, he is instrumental in leading the centre's efforts in developing a large GIST and soft tissue / bone sarcoma database, the first of its kind in Singapore, to study its unique disease patterns in our Asian patients.
Dr Quek is also heavily involved in developing local, regional and international collaborations to improve clinical care and research for patients. Notably, he is the Principal Investigator of many clinical trials studying novel new drugs in the treatment of sarcoma and GIST patients.
Mark Puhaidran graduated from the National University of Singapore in 1998. He completed his MRCS training in 2004, and completed his specialist training in hand surgery in 2007, and did his fellowship training in musculoskeletal oncology at Memorial Sloan-Kettering Cancer Center from 2008 - 2010.
His interests include extremity tumours and microsurgical reconstruction following tumour resection.
Dr Chin Kuok Choon Francis graduated from NUS in 1999 and did a MSc in Radiation Biology in UCL, London as a Chevening scholar, obtaining a distinction. He completed his fellowship and specialization in London in clinical oncology.
Currently a senior consultant sub-specializing in hepatobiliary, gastrointestinal, gynae-oncology, paediatrics and soft tissue sarcomas. He has publications in various topics like radiation disaster management, radiobiology and clinical oncology. He is also principal investigator in various research and quality improvement projects.
A/Prof Tan Mann Hong completed his medical undergraduate studies in 1985 from the National University of Singapore (NUS). He went on to complete his orthopaedic surgical training in 1994. In the same year, he was awarded the Ministry of Health, Singapore HMDP (Health Manpower Developmental Programme) and spent a year as a fellow in orthopaedic surgical oncology in the renowned Massachusetts General Hospital (MGH) Boston, Massachusetts, USA in 1995. He then returned to practice in the Singapore General Hospital since 1996.
His main interests within orthopaedic surgery are in musculoskeletal tumours, limb sarcomas involving bone and soft tissues, limb salvage surgery, limb reconstructive surgery with mega-endoprostheses and bone allografts, joint replacement surgery, minimally invasive surgery with percutaneous radiofrequency ablation of bone tumours, computer aided surgery in joint arthroplasties and limb reconstruction. Since 1999, he is the Director of Musculoskeletal Tumour Surgery in SGH. Dr Tan has been instrumental in setting up SGH as the main referral centre for musculoskeletal tumour surgery and limb salvage reconstructive surgery.
A/Prof Tan has cultivated limb salvage surgery in the use of mega-endoprostheses and bone allografts, especially in bone segment replacement for limb sarcomas. He has introduced minimally invasive surgery with percutaneous radiofrequency ablation of bone tumours in Singapore. He also chairs regular sarcoma board conferences with a multi disciplinary team of oncologists, pathologists and radiologists from the Singapore General Hospital and the National Cancer Centre.
A/Prof Tan is also an invited local and overseas speaker for various scientific symposiums on the topics of limb salvage surgery and reconstructive surgery, as well as musculoskeletal tumour topics. He has presented many papers during his European Travelling Fellowship in EFFORT in 1996, the ASEAN region during the ASEAN Orthopaedic Meetings, Musculoskeletal Tumour Society’s Scientific meetings, and in China as well. He has also conducted knee arthroplasty workshops overseas for the regional ASEAN medical institutions and hospitals.
A/Prof Tan is also highly involved in undergraduate and post graduate medical teaching in the faculties of Yong Loo Lin School of Medicine, NUS as well as Duke-NUS. He is part of the Core Faculty in the Singhealth Orthopaedic Residency Program, and is also involved Specialist Training Committee in Orthopaedic Surgery of the Ministry Of Health. He is well published with over 35 publications, and is a reviewer with distinction for the Singapore Medical Journal, as well as the Annals, Academy of Medicine.
Dr Choo Bok Ai obtained his medical degree from the University of Aberdeen in the United Kingdom. He completed his internal medicine and advanced specialist training in clinical oncology in the UK and hold postgraduate qualifications from the Royal College of Physicians (MRCP) and the Royal College of Radiologists (FRCR). He was awarded the Certificate of Completion of Specialist Training in Birmingham, United Kingdom.
Dr Lester Chan is a consultant orthopaedic surgeon and a member of the Tan Tock Seng Hospital orthopaedic tumour team. He graduated from Imperial College School of Medicine in 2004. He completed orthopaedic training in Singapore in 2014 and an orthopaedic oncology fellowship at St Vincent's Hospital Melbourne in 2016. In his free time he enjoys playing the guitar and running after his two children.
Education and Fellowships
MBBS (Singapore), MRCP (UK)
Specialty Interests
-
Gastrointestinal Cancers
-
Sarcoma
-
Phase I Clinical Trials
Professional Memberships
-
American Society of Clinical Oncology
Publications
-
Editor's quiz: GI snapshot; Gut, Volume 58; Issue 6 - A case of persistent vomiting. A Pang1, P L Chia1, B Ang2, S A Buhari3, B Y S Chuah1 Gut2009;58:750; doi:10.1136/gut.2008.167643.
-
A case of sweet's syndrome due to 5-Azacytidine and vorinostat in a patient with NK/T cell lymphoma.Pang A, Tan KB, Aw D, Hsieh WS, Goh BC, Lee SC. Cutaneous and Ocular Toxicology. 2012 Mar;31(1):64-6. doi:10.3109/15569527.2011. 602034. Epub 2011 Aug 26.
-
Cancer physicians’ attitude towards treatment of the elderly cancer patient in a developed Asian country. Angela Pang, Shirlynn Hoand Soo-Chin Lee BMC Geriatr. 2013 Apr 16;13:35. doi: 10.1186/1471-2318-13-35.
-
Hepatitis B virus reactivation risk varies with different chemotherapy regimes commonly used in solid tumours. Ling WH, Soe PP,PangAS, Lee SC. Br J Cancer. 2013 May 28;108(10):1931-5. doi: 10.1038/bjc.2013.225. Epub 2013 May 7.
Dr Henry Soeharno Lim graduated from the University of New South Wales, Sydney, Australia in 2005. Migrated to Singapore in 2009 and entered Orthopaedic Surgery in 2010. Completed FRCS (Ortho) in 2015 and currently an Associate Consultant at Singapore General Hospital with a special interest in Orthopaedics Musculoskeletal Oncology
Dr Mohamad Farid Bin Harunal Rashid is a medical oncologist by training and a member of the pediatrics/ sarcoma/ melanoma workgroup for NCCS Cancer Service Line Development. He was integral in setting up the sarcoma/ GIST clinical database at NCCS. His clinical interests lie in using clinicopathologic correlative studies to enhance understanding of sarcoma biology to guide therapeutic decisions, and exploring novel strategies with established agents to enhance outcomes of systemic therapy in sarcoma.
Dr Prasad Iyer joined the paediatric haematology/oncology department at KK Women’s and Children’s hospital in February 2014. He completed his advanced specialist training from Manchester (UK) in February 2010. He pursued further training in paediatric and adolescent oncology at The Great North Children’s Hospital (Royal Victoria Infirmary) Newcastle (UK). His interests include teenage/adolescent oncology, leukaemia, lymphoma and bone marrow transplantation. He also has a keen interest in contributing to the education and training of junior doctors and medical students.
Dr Chan Lai Peng is a Senior Consultant Radiologist with the Department of Diagnostic Radiology. She is currently the Deputy Head of the Department of Diagnostic Radiology overseeing Clinical Services as well as the Deputy Director of the department’s Information Technology section.
She obtained her fellowship of the Royal College of Radiologists in 1997 and did fellowship training in musculoskeletal radiology in Vancouver General Hospital in 2001. She is a Fellow of the Academy of Medicine, Singapore, a member of the Singapore Radiological Society, Asian Musculoskeletal Society and Medical Ultrasound Society. Dr Chan also holds a Clinical Lecturer appointment from the National University of Singapore.
Her subspecialty interest is in musculoskeletal imaging, especially imaging of sports injuries, multiple myeloma and musculoskeletal tumours. Her current research projects include MR imaging of multiple myeloma, gated 4D CT scanning of the wrist for detection of instabilities, and post marketing survey of Ultravist. She has won awards for the best free paper at the 7th Annual Scientific meeting of the Singapore Radiological Society and the First International Conference on Evidence-based Medicine. She has given lectures in both international and regional conferences.
Dr Chan’s current interests are in musculoskeletal radiology, ultrasound and medical informatics.
Dr Amos Loh obtained his medical degree from the National University of Singapore in 2002 and went on to train in general surgery and then paediatric surgery. He was appointed a Member of the Royal College of Surgeons of Edinburgh in 2006 and appointed a Fellow of the Academy of Medicine, Singapore in 2011. He was awarded the College of Surgeons Gold Medal in paediatric surgery in 2011. From 2011-2013, he trained as a fellow in paediatric surgical oncology at St Jude Children’s Research Hospital in Memphis, TN. He was awarded a National Medical Research Council research training award in 2013 and did a research fellowship in the lab of Michael Dyer, PhD, in St Jude Children’s Research Hospital. He is presently a Consultant with the Department of Paediatric Surgery, KK Women’s and Children’s Hospital, with a clinical practice and academic research focus in paedatric surgical oncology.
His areas of interest are clinical and translational research in paediatric solid tumours, and has his lab research based in the National Cancer Centre Singapore. In particular, he is interested in the development of models of paediatric solid tumors for the conduct of preclinical trials of novel potential treatment strategies. He is also interested in the discovery of biomarkers for prognostication and therapeutic stratification of paediatric solid tumours, particularly neuroblastoma, osteosarcoma, and paediatric renal tumours, using 'omics and next-generation sequencing platforms.
Dr James Hallinan has been practicing in Singapore since 2008 and is an Associate Consultant at the Department of Diagnostic Imaging, National University Hospital, Singapore. He obtained his medical degree (MBChB) from Bristol University, United Kingdom and underwent radiology training at the National University Hospital, Singapore. He is a Fellow of the Royal College of Radiologists, United Kingdom. His subspeciality interests are in musculoskeletal and neuroradiology.
Graduated from Stanley Medical College, Chennai, India and did post-graduation from Madras Medical College, Chennai, India.Did Masters in Clinical Science from NUS, Singapore; submitted thesis in breast cancer and Her2neu in Singapore. Obtained FRCPath from Royal College, UK.
Working as Consultant Pathologist, Singapore General Hospital; subspecialized in Bone and Soft tissue Pathology, did training under renowned specialist in this field, Prof. Andrew Rosenberg.
EDUCATION
-
MBBS, Stanley Medical College, India (1993)
-
Post Graduate Diploma in Clinical Pathology, Madras Medical College, India. (2000)
-
Masters in Clinical Science, National University of Singapore, Singapore. (2003)
-
FRCPath, Royal College of Pathologists, United Kingdom (2010)
-
FAMS, Singapore (2010)
Dr Shui-Yen Soh is a consultant from the Paediatric Haematology / Oncology Service, KK Women's and Children's Hospital (KKH), Singapore. Dr Soh received her medical degree from the National University of Singapore, and completed her post-graduate Paediatric Medicine training at KKH.
She also completed a one-year Paediatric Oncology clinical fellowship at the Hospital for Sick Children in Toronto, Canada. Dr Soh's area of interest is in paediatric solid tumours, such as neuroblastoma, retinoblastoma, brain tumours and sarcomas. She is the co-investigator for the study on the use of sunitinib in paediatric patients with advanced gastrointestinal stromal tumours (GIST) in Singapore
Dr Sethi Vijay Kumar graduated with MBBS from the University of Singapore in 1971. After as a radiation oncologist, in the United Kingdom, he returned to Singapore to work in the Department of Radiation Oncology of the Singapore General Hospital and he has remained in service till today. Over the years, as a senior consultant radiation oncologist, he has held the following positions in the National Cancer Centre, Singapore (NCCS); Head of the department of Radiation Oncology, Chairman of the Medical Board, chair of its Research Ethics Board and is now NCCS senior advisor.
He has a particular interest in breast cancer and malignant sarcoma.
Dr Victor K Lee is a Senior Consultant with the Department of Pathology, National University Hospital, an Assistant Professor in Pathology at the Yong Loo Lin School of Medicine and the Program Director for Residency Pathology Programme at the National University Health System (NUHS), Singapore. He is a medical graduate from Melbourne University and a fellow of the Royal College of Pathologists Australasia. He has obtained his anatomical pathology training in the Monash Medical Centre (Melbourne), ACT pathology and Royal Prince Alfred Hospital, Sydney.
Dr Lee’s subspecialty interests include soft tissue, bone, brain and molecular pathology. He underwent expert training in neuropathology in Australia at the University of Sydney (under Prof. C Harper), soft tissue and bone pathology training in the United States at the University of Chicago (under Prof. A Montag & T. Krausz) and Emory University(under Prof. S Weiss).
Currently, he has an active research interest in sarcoma and bone tumours, pathology informatics and molecular pathology with contributions in peer reviewed articles in basic science and pathology journals and book chapters. Dr Lee has been regularly invited to speak at both local and international platforms. In medical education, he helps to deliver pathology teaching and tutorials to the medical, pharmacy and dentistry undergraduates. He also conducts postgraduate teaching in neuropathology, bone and soft tissue pathology for pathology and orthopaedic residents.
Dr Jonathan Teh is presently a Consultant Radiation Oncologist at the Department of Radiation Oncology, National Cancer Centre Singapore (NCCS). He started his Radiation Oncology residency at the NCCS in 2007 and received the Singhealth Health Manpower Development Programme award for advanced training in clinical oncology in 2009. He was an Honorary Clinical Fellow in the Oncology department of the University College London Hospital from 2009 – 2011.
During this time, he worked as a member of the London Sarcoma Service, one of the largest sarcoma services in Europe providing patient care and conducting clinical trials for all varieties of sarcoma including adolescent and young adult sarcoma. He was conferred the Fellowship of the Royal College of Radiologists, UK, under the chapter of Clinical Oncology in 2011.
He continues to practice sarcoma radiotherapy as part of the multi-disciplinary sarcoma team in NCCS, with particular interest in the use of advanced image-guidance and radiotherapy delivery techniques like tomotherapy to improve tumour control while reducing normal tissue toxicity. Besides sarcoma, he also practices paediatric, urologic and gastrointestinal radiotherapy.
Dr. Grace Tan graduated from Guy’s King’s and St Thomas’s College of Medicine in London, UK in 2005. Since then, she returned to complete her surgical training at Singapore General Hospital and the National Cancer Centre Singapore. As a specialist, her focus is in Gastrointestinal Cancers, Peritoneal and Pelvic malignancy and Sarcomas. She has published extensively in these areas, and despite her research endeavours, her passion is in providing the best holistic care for patients with cancer.
In 2016, she completed her fellowship training in Peritoneal Malignancy at the NHS Peritoneal Malignancy Unit in Basingstoke, UK; and pelvic oncology training at King Chulalongkorn Memorial Hospital, Bangkok, Thailand. The Basingstoke Peritoneal Malignancy Unit is one of two expert centres in the entire United Kingdon, and a leading institution in the world for the treatment of peritoneal-based malignancies, and has performed over 1200 Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedures. The King Chulalongkorn Hospital in Bangkok is one of the largest tertiary referral hospitals in Thailand and with internationally recognised expertise in the management of advanced pelvic cancers.
Dr. Tan is also a clinical tutor at the Yong Loo Lin School of Medicine at the National University of Singapore, an Adjunct Instructor with SingHealth Duke-NUS Oncology Academic Clinical Programme, and a Physician faulty of the Singapore General Hospital Residency programme. She believes that the education of the next generation of doctors is an integral part of the art of medicine.
A/Prof Melissa Teo is a Senior Consultant in Division of Surgical Oncology and the Director of the NCCS Centre for Peritoneal and Pelvic Disease.
Dr Melissa Teo is one of only three accredited surgical oncologists in Singapore. She completed her surgical residency in Singapore and in 2007, was awarded the Singhealth HMDP Award to pursue sub-specialty training in complex intra-abdominal and pelvic surgery in the University of Toronto/ Princess Margaret Hospital, Toronto, Canada.
On top of her Surgical Oncology Fellowship, she also completed her Colorectal Surgery Fellowship. Interested in policy development, she received an NMRC Award to study at John Hopkins Bloomberg School of Public Health, and graduated in 2009 with a Master of Public Health.
A strong advocate for improving cancer care in Singapore, she is an executive council member of Singapore Society of Oncology, a member of the MOH workgroup for evaluation and financing of screening and treatment modalities, a member of the Gastrointestinal Tract for NCCS Cancer Service Line development, and co-chair of the paediatrics / sarcoma / melanoma workgroup for NCCS Cancer Service Line Development.
Dr Steven Wong is the Head of Department of Radiology at Sengkang General Hospital, in Singapore. He is an Adj Assistant Professor in Radiology at Dukes-NUS Graduate School of Medicine, Singapore and a Consultant Musculoskeletal Radiologist at Singapore General Hospital.
He has interests in the imaging of Sports Injuries, Articular Cartilage disorders and Bone and Soft Tissue Sarcomas as well as Interventional Musculoskeletal Radiological procedures.
He is also involved in Radiology IT and Imaging Informatics matters with Singapore General Hospital and the Imaging Informatics Community in Singapore and is also a member of SIIM (USA).
He is the Chairman of the Enterprise Imaging Track Organising Committee for the October 2016 HIMSS Asia Pacific Digital eHealth Innovations Summit.
He is a Member of the Examination Board for the Final MMed (Diagnostic Radiology) and Final FRCR Examination, Division Of Graduate Medical Studies, NUS, Singapore.
Dr Shui-Yen Soh is a consultant from the Paediatric Haematology / Oncology Service, KK Women's and Children's Hospital (KKH), Singapore. Dr Soh received her medical degree from the National University of Singapore, and completed her post-graduate Paediatric Medicine training at KKH.
She also completed a one-year Paediatric Oncology clinical fellowship at the Hospital for Sick Children in Toronto, Canada. Dr Soh's area of interest is in paediatric solid tumours, such as neuroblastoma, retinoblastoma, brain tumours and sarcomas. She is the co-investigator for the study on the use of sunitinib in paediatric patients with advanced gastrointestinal stromal tumours (GIST) in Singapore
Dr Shui-Yen Soh is a consultant from the Paediatric Haematology / Oncology Service, KK Women's and Children's Hospital (KKH), Singapore. Dr Soh received her medical degree from the National University of Singapore, and completed her post-graduate Paediatric Medicine training at KKH.
She also completed a one-year Paediatric Oncology clinical fellowship at the Hospital for Sick Children in Toronto, Canada. Dr Soh's area of interest is in paediatric solid tumours, such as neuroblastoma, retinoblastoma, brain tumours and sarcomas. She is the co-investigator for the study on the use of sunitinib in paediatric patients with advanced gastrointestinal stromal tumours (GIST) in Singapore
Dr Nicholas Brian Shannon received his BS in Biochomesitry from the University of York before pursuing his PhD in the University of Cambridge. He is now pursuing his MD in Duke-NUS medical School Singapore and is active in clinical and translational research.
His research interests includes the Molecular biology of cancer progression, dedifferentiation and metastasis, identification of prognostic signatures, novel drug targets and pathways in advanced epithelial cancers, peritoneal carcinomatosis and retroperitoneal sarcomas.
He is also trained in biostatistics and is a study member for Validation of Locoregional Recurrence Genes for Decision of Adjuvant Radiotherapy and Chemotherapy (VALUERTCT). He received the abstract award during the 2012 UEGW conference in Amsterdam, and the 2016 JSMO conference in Japan
Dr Chetan completed medical school at the Mahatma Gandhi Institute of Medical Sciences Sewagram in India. Having a keen interest in research, he pursued a Master of Science degree in Molecular Medicine from Penn State University Pennsylvania USA. Subsequently, he completed his training in Paediatrics from Cook County Hospital in Chicago and a fellowship in Paediatric Oncology from MD Anderson Cancer Centre in Houston.
During his fellowship, he worked in the laboratory, studying T regulatory cells and the basis of cellular therapy in cancer treatment. He specialises in the treatment of paediatric bone and soft tissue sarcomas. He is also interested in the application of cell based therapies for solid tumors in the clinical setting.
Dr Chetan and a team of physicians from the National University Cancer Institute, Singapore (NCIS) are spearheading an Adolescent and Young Adult team to meet the special requirements of cancer patients between the age group of 18 to 25 years as they are a unique group who do not fall completely under the realm of paediatrics or in the elderly age group.
APN Foong Li Li is an Orthopaedic Advanced Practice Nurse in NUH. She obtained her Master in Nursing from National University Singapore in 2012. Her portfolio of patients include Musculoskeletal Oncology and Hip and Knee Joint Replacement. Together with Dr. Choo Bok Ai, they launched the Singapore Sarcoma Support Group in 2016.
At 85 years of age, Mr Chang has lived a life full of challenges and experiences. A World War ll survivor, a teaching career that spanned 33 years, but none more so than his battle with cancer. He was first diagnosed with Sarcoma in 2011 and in 2015 had to undergo an above elbow amputation when his cancer relapsed. He has since been a shining inspiration to all who have come to know him for his amazing spirit, positive attitude and generosity in time and heart. Joining the Sarcoma Support Group has given Mr Chang a platform where he finds common ground and empathy with fellow patients, survivors, and caregivers. They have been a pillar of support for him. In Mr Chang’s words:
“At the end of the day, we all die. It is whether we live a good life or not. For me, living with one arm may be an inconvenience, but that does not stop me from leading a good life and keeping active.”
